Summary:
- This article discusses PYC Therapeutics, a biotechnology company that has raised $653 million to develop RNA-based therapies.
- PYC Therapeutics is working on using RNA technology to treat diseases by targeting the underlying genetic causes.
- The funding will allow the company to advance its research and potentially become a leader in the field of RNA-based treatments.